Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=43 Randomized Double-blind Treatment

A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)

Posttraumatic Stress Disorder · Depression · Insomnia Disorder

Bottom Line

View on ClinicalTrials.gov: NCT00984698 ↗
Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Mar 2014
Primary outcome: Primary: Depression — 20.30; 19.18 units on a scale — p=<.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive Behavioral Social Rhythm Group Therapy (Behavioral); Present Centered Group Therapy (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
University of Arizona
Primary completion
May 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Depression		 20.30; 19.18 <.05 sig
SECONDARY
PTSD		 67.35; 62.47 <.05 sig

Summary

The purpose of this study is to test the effectiveness of group psychotherapy designed specifically for male veterans and active-duty personnel with Post-traumatic Stress Disorder (PTSD), Major Depressive Disorder (MDD) and with disturbances in their sleep or daily routine.

Eligibility Criteria

Inclusion Criteria

  • Veteran or active duty military personnel
  • Current posttraumatic stress disorder (PTSD), at least moderate severity
  • Criterion A exposure to trauma occurring after the age of 18
  • Major depressive disorder (MDD), at least moderate severity
  • Disturbances in sleep (primary insomnia, insomnia related to PTSD, or nightmare disorder) or daily routine

Exclusion Criteria

  • Current or past bipolar disorder
  • Current psychotic disorder
  • Substance abuse/dependence in last 30 days
  • Uncontrolled serious medical condition or neurological disorder
  • Currently working an overnight shift
  • Primary untreated sleep apnea, restless legs syndrome
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00984698). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search